MR imaging of female pelvic malignancies

Magnetic Resonance Imaging Clinics of North America

Volumn 8, Issue 4, 2000, Pages 887-914

  Audet, P ^a   Pressacco, J ^a   Burke, M ^a   Reinhold, C ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER STAGING; CHORIOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PELVIS CANCER; REVIEW; UTERINE CERVIX CARCINOMA; UTERUS SARCOMA; VAGINA CARCINOMA;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 0033669129     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Carcinoma of the uterine cervix: High-resolution turbo spin-echo MR imaging with contrast-enhanced dynamic scanning and T2-weighting
2. MR imaging of the female pelvis: The time has come
3. Adnexa
4. Exploratory celiotomy for surgical staging of cervical cancer
5. The effect of tamoxifen on the endometrium
6. Carcinoma of the ovary. A clinicopathologic study of 86 autopsied cases with special reference to mode of spread
7. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions
8. Results of surgical treatment of 1028 cervical cancers studied with volumetry
9. Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II
10. The adnexae
11. Current status of MR imaging of the female pelvis
12. Female genital tract
13. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
14. Primary carcinoma of the vagina
15. Tumor recurrence versus fibrosis in the female pelvis: Differentiation with MR imaging at 1.5 T
16. Female urethra and vagina
17. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
18. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
19. Imaging of ovarian cancer
20. Ovarian cancer: Staging with CT and MR imaging
21. Ovarian cancer recurrence: Value of MR imaging
22. The fallopian tube
23. Premalignant and malignant disorders of the uterine cervix
24. Benign conditions of ovary
25. Current trends in MR imaging of the female pelvis
26. MR imaging evaluation of endometrial carcinoma: Results of an NCI cooperative study
27. Clear cell adenocarcinoma of the vagina and cervix in girls: Analysis of 170 registry cases
28. Carcinoma of the uterus: Use of gadopentetate dimeglumine in MR imaging
29. Invasive cervical carcinoma: Role of MR imaging in pretreatment work-up - Cost minimization and diagnostic efficacy analysis
30. Carcinoma of the cervix: Predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors
31. Irradiation of the cervix uteri: Value of unenhanced and contrast-enhanced MR imaging
32. Endometrial carcinoma and tamoxifen: Clearing up a controversy
33. Sarcomas of the uterus: A clinicopathologic study of 119 patients
34. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries
35. Primary malignant tumor of the fallopian tube: Appearance at CT and MR imaging
36. Comparison of the use of the transrectal surface coil and the pelvic phased-array coil in MR imaging for preoperative evaluation of uterine cervical carcinoma
37. Uterine cervical carcinoma: Comparison of CT and MR findings
38. Radiologic staging in patients with endometrial cancer: A meta-analysis
39. Adnexal masses: Transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure
40. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
41. Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group
42. Cancer statistics, 1999
43. MR imaging of invasive carcinoma of the uterine cervix
44. Ultrasonic morphology of the uterus and ovaries after treatment of invasive mole and gestational choriocarcinoma
45. Ovarian cancer: Comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT
46. Treated ovarian cancer: Comparison of MR imaging with serum CA-125 level and physical examination - A longitudinal study
47. High-risk metastatic gestational trophoblastic tumors: Current management
48. Carcinoma of the fallopian tube
49. Cervical cancer: Application of MR imaging in radiation therapy
50. Postoperative radiation therapy in clinical stage I endometrial cancer: Corpus, cervical, and lower uterine segment involvement - Patterns of failure
51. Magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses
52. Tumors of the ovary: General considerations, classification, the adnexal mass
53. Vaginal metastases of hypernephroma
54. Gestational trophoblastic diseases
55. Papillary projections in ovarian neoplasms: Appearance on MRI
56. Normal ovaries and functional cysts: MR appearance
57. Magnetic resonance imaging of the ovary
58. Epithelial ovarian cancer
59. Malignant lymphoma with primary manifestation in the gonad: A clinicopathologic study of 38 patients
60. Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: Initial experience
61. Cervical carcinoma: Can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness?
62. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer
63. Uterus and cervix
64. Endometrial carcinoma
65. Stage IB cervical carcinoma: Comparison of clinical, MR, and pathologic staging
66. Analysis of preoperative intracavitary cesium application vs postoperative external beam radiation in stage I endometrial carcinoma
67. Radiological evaluation of lymph node metastases in patients with cervical cancer
68. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
69. Clinical stage I endometrial carcinoma: Pitfalls in preoperative assessment with MR imaging
70. Stromal invasion by carcinoma of the cervix: Assessment with dynamic MR imaging
71. Primary ovarian cancer: Prospective comparison of contrast-enhanced CT and pre- and postcontrast, fat-suppressed MR imaging with histologic correlation
72. Myometrial invasion by endometrial carcinoma: Assessment with plain and gadolinium-enhanced MR imaging
73. Carcinoma of the cervix: Value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness
74. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities
75. Identification and management of high-risk gestational trophoblastic disease
76. Carcinoma of the cervix treated with radiation therapy I: A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group
77. Uterine cervix
78. Ovarian lesions: Detection and characterization with gadolinium-enhanced MR imaging at 1.5 T
79. A 30-year experience in the management of primary carcinoma of the vagina: Analysis of prognostic factors and treatment modalities
80. Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging
81. Ovarian masses revisited: Radiologic and pathologic correlation
82. Gadolinium-DOTA enhanced MR imaging of adnexal tumors
83. Invasive adenocarcinoma of the uterine cervix: MR imaging
84. The staging of cervical cancer: Inevitable discrepancies between clinical staging and pathologic findings
85. Ovarian epithelial neoplasms: Radiologic-pathologic correlation
86. Vaginal metastases of carcinoma of the body of the uterus
87. Cervical carcinoma: Determination of recurrent tumor extent versus radiation changes with MR imaging
88. Adnexal masses: Accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging
89. Contrast-enhanced dynamic MR imaging of postmolar gestational trophoblastic disease
90. Preoperative staging of cervical carcinoma: Phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging
91. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix
92. Peritoneal washing cytology in gynecologic cancers: Long-term follow-up of 355 patients